Targeted Cancer Therapy Cost in India (2026): A Full Breakdown by Drug Type, Cancer, Testing and Length of Treatment
Targeted therapy is a monthly cost, not a one-off. Here's what each drug type costs in India, what testing adds, and what a quote leaves out.
Targeted Cancer Therapy Cost in India (2026): A Full Breakdown by Drug Type, Cancer, Testing and Length of Treatment
Targeted therapy is priced differently from almost every other cancer treatment. It is usually not one bill for one procedure. It is a monthly cost that continues for as long as the drug keeps working.
That single fact changes how you should budget. The right question is not "what does targeted therapy cost in India," but "what does my drug cost per month, and for how long am I likely to need it?"
This page breaks that down honestly — by drug type, by cancer, by testing, and against UK and US prices — and shows what usually sits outside a quoted price so nothing surprises you later.
For the full clinical picture, start with the main guide: targeted cancer therapy India →
| Targeted therapy in India | ~USD 8,000–12,000 |
| What that band covers | Hospital, medication, coordination |
| Same treatment in Singapore | ~USD 10,000–50,000 |
| Same treatment in the UAE | ~USD 5,500–54,000 |
| Online consultation | ~USD 38–64 |
| Typical first visit to India | ~2–4 weeks |
- 1What targeted therapy costs in India
- 2Why it's an ongoing cost, not a one-off
- 3Cost by cancer type
- 4Cost by city
- 5The cost of testing before treatment
- 6What's inside the price — and what isn't
- 7What actually moves your final cost
- 8Why it costs less in India
- 9India vs the UK, USA and Gulf
- 10India vs other medical-travel destinations
- 11Travel, stay and continuing at home
- 12Does the hospital change the price?
- 13Paying for it — insurance and funding
- 14How to get an accurate quote
- 15Frequently asked questions
What Targeted Therapy Costs in India
Targeted cancer therapy in India costs approximately USD 8,000–12,000, according to figures published by the medical-travel platform MediGence in 2026. That band is described as covering the hospital, medication and care coordination.
Where you fall inside it depends mainly on the drug prescribed and how long treatment runs.
Two things are worth saying plainly about that number before you rely on it.
First, it is a band, not a quote. Targeted therapy is not a single procedure with a fixed price — it is a course of drug treatment, and the drug is by far the largest variable.
Second, published figures for this treatment vary enormously between sources. That is not dishonesty so much as different things being measured: a treatment package, a monthly drug supply, or a single infusion are all quoted as "the cost of targeted therapy."
Some sites quote a treatment package. Others quote a month of tablets. Others quote one vial of an infused drug. All three get labelled "targeted therapy cost," which is why you will see figures that differ by a factor of ten.
When comparing quotes, always ask what unit the price refers to, and over what period.
Want a figure for your case, not a band?
Send your diagnosis and any molecular test results. We come back with a written estimate for the drug you actually need, from accredited hospitals. Free, within 24 hours.
Get My Estimate on WhatsApp →Why It's an Ongoing Cost, Not a One-Off
Unlike surgery, targeted therapy usually continues for as long as it keeps the cancer controlled. A published treatment band covers the initial course; the drug supply afterwards is a separate, recurring cost.
Budget for both — the first episode and the monthly run rate that follows.
This is the point most cost pages skip, and the one that causes the most difficulty later. A family budgets for a trip and then discovers the real commitment is recurring.
So ask for two numbers, always. The first is what the initial visit costs — testing, consultations, travel and starting treatment.
The second is what the drug costs each month afterwards, once treatment continues at home. Together they are the honest picture; either alone is misleading.
Because most targeted therapies are tablets, many patients only need to be in India for the initial workup and stabilisation. Treatment then continues at home.
Indian-manufactured generics can often still be sourced legally afterwards, which is why the ongoing cost stays comparatively low even after you leave.
Cost by Cancer Type
Cost follows the drug, and the cancer largely decides which drug you need. Chronic myeloid leukaemia sits at the affordable end because long-established generic tablets are made in India.
Lung, breast and ovarian cancers vary far more, depending on which mutation is found and whether a generic or biosimilar exists for it.
We describe relative position rather than publishing a price per cancer, because two patients with the same diagnosis can need very different drugs.
Relative positions only. Ask your oncologist for the drug name, then ask us to price that specific drug — that is the only way to get a figure you can plan around.
For the drug detail behind each, see the cancer-specific guides: lung → · breast → · colorectal → · blood cancers →
See the cost for your exact diagnosis
Share the diagnosis and reports and we return a figure built around your case and your mutation, not an average. Free, within 24 hours.
Get a Diagnosis-Specific Estimate →Cost by City
Published costs for targeted therapy are essentially identical across India's major treatment cities. Delhi, Gurgaon, Mumbai, Chennai, Bengaluru, Hyderabad, Kolkata and Noida are all listed at approximately USD 8,000–12,000, with only smaller cities quoted lower.
Choosing a city for price alone is therefore the wrong optimisation.
City bands as published by MediGence, July 2026. The near-uniformity across metros is itself the useful finding: location is not a meaningful cost lever for this treatment.
You will still see "targeted therapy cost in Delhi" and "cost in Mumbai" advertised as though they were different propositions. On the published evidence, they are not.
What should decide your city is flight connections, whether the hospital has in-house molecular testing, and the unit's experience with your specific cancer.
The Cost of Testing Before Treatment
Biomarker testing is a one-time cost that comes before treatment and is normally billed separately from any treatment package. A single-gene test costs considerably less than a full next-generation sequencing panel.
Without this testing, no oncologist can prescribe targeted therapy responsibly.
A single-gene test answers one question, such as whether a lung cancer carries an EGFR mutation. A broad panel checks many genes at once and can surface options a narrow test would miss.
Which is right depends on your cancer. For a clear single-driver cancer, a focused test is often enough. For rare cancers, or when standard options have run out, the broader panel usually earns its cost.
We do not publish a fixed price for these tests, because panel pricing varies widely by laboratory and by how many genes are covered. Ask which panel is being used, what it covers, and what it costs, in writing.
If you have already had molecular testing at home, send us the report before you travel. It is often accepted and does not need repeating.
Equally, if you have had a biopsy or surgery anywhere, the stored tissue block can usually be tested. A new biopsy is frequently unnecessary.
The full process is explained here: Biomarker testing before targeted therapy →
Send your existing reports before you pay for new tests
We will tell you honestly whether your existing testing is enough, or what still needs doing — which often saves both time and a repeated test fee.
Check My Existing Reports →What's Inside the Price — and What Isn't
A targeted therapy quote in India usually covers the drug itself, its administration, and routine monitoring during treatment. It usually excludes molecular testing, scans, treatment of side effects, hospital admission if complications occur, and all travel and accommodation.
Always confirm what a quote includes in writing.
This is where families get caught out. A low headline number often covers the drug alone, and everything around it arrives as separate bills.
Get these in writing: is this the generic or the originator drug; is molecular testing inside or outside the quote; what is the cost per month after the first cycle; and what happens to the price if the drug has to be changed.
GAF Healthcare confirms all four in writing before you travel.
What Actually Moves Your Final Cost
Five things drive the final cost: whether a generic or biosimilar version of your drug exists, the dose you need, how long you stay on treatment, whether the drug is used alone or with chemotherapy, and whether resistance later forces a switch to a newer, costlier drug.
Generic or originator. This is the biggest single lever. An Indian-made generic or biosimilar can cost a fraction of the imported originator, for the same molecule and the same regulatory standard.
Your dose and body weight. Many infused drugs are dosed by weight or body surface area. A larger adult simply needs more drug per cycle, and the cost tracks that.
Duration. The longer a drug keeps working, the more it costs in total — which is the strangest arithmetic in oncology, because a long run is good news clinically.
Combination treatment. Targeted therapy is often given alongside chemotherapy or hormone therapy. Each added agent has its own cost, and the quote should itemise them separately.
Resistance and switching. If the cancer develops resistance, you may move to a next-generation drug that costs more. Build some headroom into the plan rather than budgeting to the exact rupee.
How resistance and switching work clinically is covered in the main guide: targeted cancer therapy India →
Why It Costs Less in India
Targeted therapy costs less in India mainly because the drugs are manufactured there. India is one of the world's largest producers of generic medicines and biosimilars, so many targeted drugs are made domestically rather than imported.
Lower hospital and staffing costs add to the difference.
This matters because it is structural, not promotional. Nobody is discounting your treatment. The drug simply costs less to put in your hand when it was made in the same country.
Generics and biosimilars are not lesser medicines. A generic contains the same active molecule as the original, and a biosimilar is a closely matched version of a biological drug, both approved against defined regulatory standards.
Accredited Indian cancer centres also follow the same international treatment protocols. What changes across the border is the price of delivering that care, not the protocol itself.
Not every targeted drug is cheaper in India. Very new agents still under patent are imported and priced closer to global levels. Ask specifically whether a generic or biosimilar exists for your drug — that answer largely determines your cost.
India vs the UK, USA and Gulf
Targeted therapy costs substantially less in India than privately in the UK, USA or the Gulf, with the widest gaps on drugs that have an Indian generic or biosimilar. The medicine and the protocol are the same; the price of supplying them is not.
We deliberately avoid publishing precise Western price comparisons, because private oncology pricing varies enormously by centre, insurer and regimen. Any single figure would be misleading.
For a like-for-like comparison, ask your local oncologist for the monthly drug cost by name, then ask us for the same drug in India. That is the only honest comparison.
For UK patients the driver is often access and timing rather than price alone. For Gulf and African patients, it is frequently whether the drug is available locally at all.
Compare your local quote against India
Send us the drug name and monthly price you have been quoted at home. We come back with the same drug priced in India, and tell you plainly if the saving is not worth travelling for.
Compare My Quote →India vs Other Medical-Travel Destinations
Among the main destinations for cancer treatment abroad, India is published at approximately USD 8,000–12,000 for targeted therapy — a narrower and lower band than Singapore, the UAE or Jordan.
The UAE and Singapore both show very wide bands, reflecting how much drug choice and hospital tier move the figure.
Destination bands as published by MediGence, July 2026. Compare like with like: a low headline band in one country may exclude drugs that another country's package includes.
For Gulf patients the calculation is often not India versus the UAE on price alone, but whether the specific drug is available and how quickly treatment can begin.
A further overview of targeted therapy options for patients travelling to India is available here: targeted therapy in India →
Travel, Stay and Continuing at Home
Most international patients starting targeted therapy need only a short first visit — often two to four weeks for testing, consultation and starting treatment.
Budget for return flights, accommodation for the patient and one companion, local transport and food, plus the ongoing drug supply once you return home.
This is where targeted therapy differs sharply from surgery or a transplant. There is usually no long hospital admission, so the travel component is comparatively small.
Accommodation. Serviced apartments and guest houses near the major hospitals are widely available, and for a stay of a few weeks the total is modest by international standards.
Infusion regimens are different. If your drug is given by IV every few weeks, you will either return periodically or arrange for infusions to continue at home. Plan this before you travel, not after.
Ongoing supply. For oral drugs, the practical question is how you obtain refills once home. This can usually be arranged, but the route differs by country and should be confirmed in advance.
For visa and stay logistics, see: Medical visa for treatment in India →
Does the Hospital Change the Price?
Less than most people expect. The drug is the dominant cost and its price is broadly similar across accredited centres. Hospitals differ more on consultation fees, day-care charges, imaging and testing rates than on the medicine itself.
This is why chasing the cheapest hospital is usually the wrong optimisation. The greater risk is being started on the wrong drug because testing was incomplete.
What genuinely matters is whether the centre has in-house molecular testing, a multidisciplinary tumour board, and real experience with your cancer type.
Accredited centres we frequently coordinate treatment through include:
→ Medanta – The Medicity, Gurgaon
→ Kokilaben Dhirubhai Ambani Hospital, Mumbai
→ Manipal Hospitals, Dwarka, Delhi
→ Max Super Speciality Hospital, Saket
Compare them here: Best cancer hospitals in India → and best hospitals for targeted therapy →
Get quotes from more than one hospital
We can request written estimates from several accredited centres so you can compare like for like, instead of taking the first number you are given.
Request Multiple Estimates →Paying for It — Insurance and Funding
Most international patients self-fund targeted therapy in India, paying per cycle or per month instead of everything upfront. Others use international insurance, employer or embassy sponsorship, or charitable and community fundraising.
Confirm in writing whether your policy reimburses treatment abroad before you travel.
Insurance. Some international policies cover overseas treatment in part. Coverage of oral drugs taken at home is often treated differently from infusions given in hospital, so ask about both.
Paying as you go. Because treatment is monthly, you are rarely asked to pay for a year in advance. That makes the cost easier to manage than a single large procedure fee.
Fundraising and support. Many families raise part of the cost through community fundraising or employer support. A clear written estimate early makes any of these far easier to organise.
GAF Healthcare does not provide financial or insurance advice, and nothing here guarantees coverage — every policy differs. What we can do is get you a clear, itemised written estimate quickly, which is the document insurers, employers and fundraisers all ask for.
How to Get an Accurate Quote
To get an accurate targeted therapy quote, send your diagnosis, pathology report, any molecular or genetic test results, and recent scans. An oncologist reviews them and returns the likely drug, the monthly cost, and what the first visit to India would involve.
Every band on this page is a guide. The only figure that matters to your family is the one produced after a specialist has read your actual reports.
Useful documents to send: the diagnosis and stage, the biopsy or histopathology report, any biomarker or NGS results, recent scans, and a list of treatments already given.
If molecular testing has not been done yet, send what you have anyway. We will tell you which test is needed first and what it costs, before anything else is committed.
Get a free, written cost estimate — within 24 hours
Send your diagnosis and reports on WhatsApp. An oncologist reviews the case and returns the likely drug, an honest monthly cost, and the right hospital. Free, no obligation — and if targeted therapy isn't right for you, we'll tell you that too.
care@gafhealthcare.com
Frequently Asked Questions
How much does targeted therapy cost in India?
Targeted cancer therapy in India costs approximately USD 8,000–12,000, according to figures published by MediGence in 2026, covering hospital, medication and care coordination. Where you fall in that band depends mainly on the drug prescribed and how long treatment continues.
Why is targeted therapy cheaper in India?
Mainly because many of these drugs are manufactured in India as generics and biosimilars rather than imported. Lower hospital and staffing costs add to the difference. The medicine and treatment protocol are the same.
Is the cost per month or one time?
Usually per month. Targeted therapy is an ongoing treatment that continues for as long as it keeps working, so you should budget for a monthly run rate rather than a single procedure fee.
Does the price include genetic testing?
Usually not. Biomarker testing is normally billed separately as a one-time cost before treatment begins. A single-gene test costs considerably less than a full NGS panel. Always ask whether testing sits inside or outside the quote.
Are generic targeted drugs as good as the original?
A generic contains the same active molecule as the original and a biosimilar is a closely matched version of a biological drug, both approved against defined regulatory standards. Ask your oncologist which version is being used and why.
How long do I need to stay in India?
Often only two to four weeks for testing, consultation and starting treatment. Because many targeted therapies are tablets, treatment can frequently continue in your home country afterwards.
Is targeted therapy cheaper in one Indian city than another?
Not meaningfully. Published bands for Delhi, Gurgaon, Mumbai, Chennai, Bengaluru, Hyderabad, Kolkata and Noida are all approximately USD 8,000–12,000. Only smaller centres are quoted lower, and the difference is modest.
Does the hospital I choose change the cost much?
Less than most people expect. The drug dominates the total and its price is broadly similar across accredited centres. Hospitals differ more on consultation, imaging and day-care charges than on the medicine itself.
What if the drug stops working?
Cancers commonly develop resistance over time. You may then be re-tested and switched to a next-generation drug, which can cost more. It is sensible to build some headroom into your budget for that possibility.
What it is, treatment goals, drug families, biomarker testing, resistance, side effects and hospitals.
Molecular testing capability, tumour boards and international-patient support compared.
The test that decides whether targeted therapy will work — and what it costs.
How the two differ in mechanism, side effects and cost.
Have a cost question about your case?
GAF Healthcare's advisors answer questions about drug pricing, testing, hospitals and visas by WhatsApp — usually within 24 hours.
Ask a Cost Question →| Written by | The GAF Healthcare team, for international patients |
| Last updated | July 2026 |
| Pricing basis | Cost bands as published by MediGence, July 2026 |
This page is patient education, not a prescription or a quotation. Every treatment decision belongs to you and your treating oncologist.
All costs are approximate and change with drug choice, dose, duration and exchange rate. Drug pricing moves as patents expire and biosimilars launch. Always obtain a written, itemised estimate before travelling.
Explore More
- Brachytherapy Cost in India (2026): Price, Types and Why It Matters Most for Cervical Cancer
- SBRT and SRS Cost in India (2026): Price, Sessions and Why the Machine Name Matters Less Than You Think
- CyberKnife Cost in India (2026): Price, Sessions and Which Tumours It Treats — for International Patients
- IGRT and VMAT Cost in India (2026): Price, Sessions and How They Differ — for International Patients